Therapeutic effects of sofalcone on experimental gastritis

Arzneimittelforschung. 1987 Aug;37(8):944-7.

Abstract

A study was made on the therapeutic effects of sofalcone (SU-88), an antiulcer agent, on erosive and atrophic gastritis induced experimentally by 6-month administration of 5 mmol/l of sodium taurocholate (TCA) in rats. A standard meal including sofalcone of 0.25% and 1.0% shortened the total length of erosions, normalized the mucosal thickness, and reduced collagenous fibers in the gastric mucosa in one month. The doses administered were 116.3 mg and 486.1 mg/kg/week for one month. Sofalcone, thus, had a good therapeutic effect on experimental erosive and atrophic gastritis in rats.

MeSH terms

  • Animals
  • Anti-Ulcer Agents / therapeutic use*
  • Body Weight / drug effects
  • Cell Division / drug effects
  • Chalcone / analogs & derivatives
  • Chalcone / therapeutic use*
  • Chalcones
  • Gastric Mucosa / pathology
  • Gastritis / chemically induced
  • Gastritis / drug therapy*
  • Gastritis / pathology
  • Male
  • Propiophenones / therapeutic use*
  • Rats
  • Rats, Inbred Strains

Substances

  • Anti-Ulcer Agents
  • Chalcones
  • Propiophenones
  • sofalcone
  • Chalcone